Summary:
A Randomized Double-Blind, Phase 2 trial of once weekly study medication compared with placebo in participants with overweight or obesity and type 2 diabetes
Qualified Participants Must:
• Age 18 or above
•
BMI greater than 27.0 kg/m2
•
Diagnosed with Type 2 Diabetes
•
Treated with Metformin for at least 90 days prior to screening
•
History of one self-reported effort to lose weight
Qualified Participants May Receive:
Compensation for Time and/or Travel, visit with Study Physician